Skip to main content
Erschienen in: BMC Ophthalmology 1/2017

Open Access 01.12.2017 | Case report

A case of pseudoxanthoma elasticum with proliferative diabetic retinopathy

verfasst von: Keigo Kakurai, Maiko Hayashi, Kanako Yamada, Norihiko Ishizaki, Yumiko Yonemoto, Seita Morishita, Ryohsuke Kohmoto, Takaki Sato, Teruyo Kida, Tsunehiko Ikeda

Erschienen in: BMC Ophthalmology | Ausgabe 1/2017

Abstract

Background

To report the case of a patient with pseudoxanthoma elasticum (PXE) and proliferative diabetic retinopathy (PDR), and discuss the relationship between PXE and diabetic retinopathy (DR).

Case presentation

A 47-year-old man with PXE presented with angioid streaks and DR in both eyes, and bilateral panretinal photocoagulation was performed for treatment. Vitrectomy had previously been performed in his right eye for vitreous hemorrhage due to PDR. Systemic findings included multiple, discrete, symmetrical, small yellow papules bilaterally in the axilla and inguinal region. Examination on presentation showed vitreous hemorrhage in his left eye, and vitrectomy was performed for treatment. Intraoperative findings showed fibrovascular membrane around the optic disc and vascular arcade. A mottled fundus (peau d’orange appearance) associated with angioid streaks was also present, yet there was no evident choroidal neovascularization (CNV). The postoperative course was satisfactory, and corrected visual acuity improved from 0.02 to 0.7 diopters.

Conclusion

Despite the peau d’orange appearance in both eyes of this case, no CNV was evident. The vitreous hemorrhage was thus attributed to PDR. Moreover, we reviewed the published literature and discuss the relationship between PXE and DR.
Abkürzungen
CNV
Choroidal neovascularization
DR
Diabetic retinopathy
IOP
Intraocular pressure
PDR
Proliferative diabetic retinopathy
PXE
Pseudoxanthoma elasticum

Background

Pseudoxanthoma elasticum (PXE) is a genetic disorder characterized by calcification of elastic fibers, skin lesions, fundus lesions, and systemic vascular complications including coronary artery lesions, lower-leg arterial lesions, and gastrointestinal bleeding [1, 2]. The mode of inheritance in most families is autosomal recessive, but PXE with autosomal dominant inheritance has also been reported [3]. PXE affects approximately 1 in 160,000 people, typically appearing as a formation of yellow papules containing abnormally calcified elastic fibers. Cutaneous lesions are seen in the neck, axilla, cubital fossa, inguinal region, and periumbilical area. Angioid streaks are typically seen in the fundus due to breaks in the Bruch’s membrane [4].
Vascular findings in PXE mainly involve changes in medium-sized and large vessels [5], but microangiopathy has also been reported [6]. In this present study, we report an interesting case of PXE with diabetic retinopathy (DR), which is a microvascular disease. To the best of our knowledge, this is the first report of a case of proliferative diabetic retinopathy (PDR) complicated with PXE that required vitreous surgery.

Case presentation

Patient

A 47-year-old male.

Chief complaint

Decreased vision in the left eye.

History of present illness

This patient was being followed-up by a local physician for angioid streaks associated with PXE and bilateral DR. The DR had previously been treated with bilateral panretinal photocoagulation. In June 2002, pars plana vitrectomy was performed in his right eye by the previous physician for vitreous hemorrhage due to PDR. In January 2004, vitreous hemorrhage also occurred in the patient’s left eye. This temporarily regressed during follow-up, yet bleeding recurred in May 2004. The patient was subsequently referred to the Department of Ophthalmology at Osaka Medical College to undergo vitrectomy surgery.

Past medical history

The patient had been diagnosed with type 2 diabetes in 2001. He began taking oral hypoglycemic drugs, and his hemoglobin (Hb)A1c was about 6% during follow-up. He was also taking antihypertensive drugs for treatment of hypertension. The patient had undergone craniotomy for a subdural hematoma in 1999, yet the details were unknown.

Family history

None of the patient’s second-degree relatives had a history PXE. His father had diabetes, and his mother had hypertension.

Findings on initial ocular examination

Upon initial ocular examination, the patient’s visual acuity (VA) was 0.04 diopters (D) (1.0 × S-11D = C-0.75D Ax15°)OD and 0.01D (0.02 × S-10.0D)OS, and his intraocular pressure (IOP) was 14 mmHg in both eyes. The anterior eye segments showed no abnormalities. Examination of the optic media showed mild nuclear cataracts bilaterally (Emery-Little classification: grade I nuclear sclerosis). Funduscopy of the right eye showed gray-white lines with rupture of the Bruch’s membrane extending radially from the optic disc (Fig. 1a). Some streaks extended to near the fovea, but no choroidal neovascularization (CNV) or subretinal hemorrhages involving the fovea were observed. The fundus displayed a peau-d’orange mottled appearance associated with angioid streaks. Vitreous hemorrhage in the patient’s left eye obscured the optic disc and the fundus could not be examined in detail (Fig. 1b).

Findings on general physical examination

Multiple, discrete, symmetrical, small yellow papules were present bilaterally in the axillae and inguinal region. Rice-grain-sized yellowish-white papules were also present in a reticular pattern bilaterally on the neck. Blood-test results were as follows: WBC 9100/μl; hemoglobin (Hb) 10.8 g/dl; Htc 32.3%; Plt 342,000/μl; total protein 6.6 g/dL; GOT 15 units; GPT10 units; LDH 196 units; BUN 37 mg/dL; Cr 2.3 mg/dL; Na 143 mEq/L; K 5.2 mEq/L; Cl 107 mEq; HbA1c 6.3%; total cholesterol 213 mg/dL; and triglycerides 224 mg/dL.

Follow-up course

Pars plana vitrectomy for vitreous hemorrhage of the left eye was performed on June 16, 2004. Fibrovascular membrane was observed around the optic disc and superior and inferior vascular arcades; the vitreous humor was adherent at these sites, but posterior vitreous detachment (PVD) was evident in the surrounding area. The fibrovascular membrane was removed with a vitreous cutter and vitreous scissors, and the preretinal hemorrhage was aspirated (Fig. 2a). The fibrovascular membranes were nearly identical to those without PXE, and there were no unusual findings in this case. Peau d’orange appearance associated with angioid streaks around the optic disc, similar to that in the right fundus, was now observed (Fig. 2b). Breaks in the Bruch’s membrane extended to near the fovea, but no CNV was observed. Since the patient was young, the lens was preserved, the surrounding vitreous humor was removed, and intraocular photocoagulation was performed to complete the surgery. The postoperative course was good, visibility of the fundus improved, and corrected VA improved to 0.7D by 3-months after surgery(Fig. 3). At 36-months postoperative, the fundus remained stable with no occurrence of CNV.

Discussion

PXE is a genetic disease characterized by a metabolic abnormality of elastin in elastic fibers, thus affecting organs with abundant elastic fibers such as the skin, eyes, and cardiovascular system [1, 2]. PXE with angioid streaks of the retina is also called Grönblad-Strandberg syndrome. The mode of inheritance may be either autosomal dominant or recessive, but autosomal recessive inheritance is the most common [3]. PXE is the most frequent systemic disorder associated with angioid streaks, occurring in about 1 in 100,000–200,000 people, and develops most often in patients between 20 and 30 years old. PXE progresses slowly, and the skin lesions include symmetrical small yellow papules in intertriginous areas such as the axilla, lateral neck, inguinal region, and on the abdomen. These papules gradually coalesce and aggregate, forming reticulated or cobblestone plaques. Due to the abnormal elastin fibers in various organs, complications often occur, including cardiovascular abnormalities, gastrointestinal bleeding, epistaxis, and intracerebral hemorrhage.
Histopathology shows calcium deposition in elastic fibers.
Angioid streaks are a degenerative disorder in which there is formation of radial streaks emanating from the optic disc due to degeneration and breaks in elastic fibers in the outer layer of the Bruch’s membrane. These occur in 80% of patients with PXE, most commonly in men. Angioid streaks usually occur in both eyes. Although the fundus is normal at birth, angioid streaks slowly progress and most often develop in patients between 40 and 50 years old. If the macula is not involved, few subjective symptoms are present and VA remains good. However, if the breaks in the Bruch’s membrane extend to the fovea, subretinal hemorrhage and fibrosis of the macula occur together with CNV, leading to metamorphopsia and central scotomas.
Patients with angioid streaks that do not extend to the macula can be followed-up, but treatment is necessary if CNV develops. If the CNV does not involve the macula, local laser photocoagulation can be performed, but the presence of subfoveal CNV requires anti-VEGF therapy and vitreous surgery to remove the neovascularization. Nevertheless, treatment outcomes generally remain poor. Systemic diseases other than PXE that are also associated with angioid streaks include Ehlers-Danlos syndrome, Paget’s disease of bone, and sickle cell disease [7].
In age-related macular degeneration and polypoidal choroidal vasculopathy, vitreous hemorrhage may occur due to CNV, but the cause of vitreous hemorrhage in our patient was probably PDR. Diabetes associated with PXE and angioid streaks has previously been reported [8, 9]. PXE usually causes systemic lesions involving medium-sized and large vessels, but systemic microangiopathy has also been reported [6], suggesting a causal relationship with DR.
Navarro-Lopez et al. [5] histopathologically examined cardiovascular tissue in PXE and reported arteriosclerosis and obstructive lesions due to degeneration and calcification of elastic fibers in the internal elastic lamina. This results in complications such as myocardial infarction, angina pectoris, arteriosclerosis obliterans, and gastrointestinal bleeding. Similar changes have also been reported in cerebral blood vessels [10]. In Mönckeberg’s arteriosclerosis with calcium deposition, the relative risk of cerebral infarction is increased [11]. The retina, like the brain, is part of the central nervous system, and similar mechanisms may also be involved in abnormalities of retinal blood vessels.
Recent research suggests that crosstalk between various factors can dynamically transform the cells constituting the vessel walls towards increased calcification, and diabetes is one factor that is known to promote calcification [12, 13]. Besides cell transformation, apoptosis also plays a role in calcification of mesenchymal cells in vessel walls (mainly vascular smooth muscle cells) [14]. Studies to date have reported these findings in relatively large vessels of the heart and kidneys, but similar mechanisms may be involved in small arterioles of the retinal vasculature. Pericyte loss is known to be important in the mechanisms of onset of DR. Pericyte apoptosis may also be deeply involved in calcification of retinal blood vessels.
An interesting report by Perdu et al., who used a capillary microscope system, described microangiopathy in a patient with PXE [6]. A capillary microscope is a specialized microscope used to observe capillaries and their blood flow in the fingertips. This type of system enables examination of capillaries without the need for painful procedures such as skin puncture and the drawing of blood [15]. Fingertip capillaries are very small, and the morphology of these vessels can undergo long-term changes due to the effects of lifestyle-related diseases such as diabetes. Perdu et al. used this technique to examine clinical and histological findings in 7 patients with PXE, and reported microangiopathy in all 7 patients.

Conclusion

In conclusion, DR in patients with PXE has seldom been reported, but this may be because PXE itself is very rare. Taking into consideration the pathophysiology described above, systemic vascular changes in PXE may indeed play some role in the progression of DR.

Acknowledgements

The authors wish to thank John Bush for editing the manuscript.

Funding

Not applicable.

Availability of data and materials

The datasets during the current study available from the corresponding author on reasonable request.
Not applicable.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.

Competing interests

The authors have no conflicts of interest to report.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
2.
Zurück zum Zitat Hu X, Plomp AS, van Soest S, Wijnholds J, de Jong PT, Bergen AA. Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. Surv Ophthalmol. 2003;48(4):424–38.CrossRefPubMed Hu X, Plomp AS, van Soest S, Wijnholds J, de Jong PT, Bergen AA. Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. Surv Ophthalmol. 2003;48(4):424–38.CrossRefPubMed
4.
Zurück zum Zitat Yap EY, Gleaton MS, Buettner H. Visual loss associated with pseudoxanthoma elasticum. Retina. 1992;12(4):315–9.CrossRefPubMed Yap EY, Gleaton MS, Buettner H. Visual loss associated with pseudoxanthoma elasticum. Retina. 1992;12(4):315–9.CrossRefPubMed
5.
Zurück zum Zitat Navarro-Lopez F, Llorian A, Ferrer-Roca O, Betriu A, Sanz G. Restrictive cardiomyopathy in pseudoxanthoma elasticum. Chest. 1980;78(1):113–5.CrossRefPubMed Navarro-Lopez F, Llorian A, Ferrer-Roca O, Betriu A, Sanz G. Restrictive cardiomyopathy in pseudoxanthoma elasticum. Chest. 1980;78(1):113–5.CrossRefPubMed
6.
Zurück zum Zitat Perdu J, Champion K, Emmerich J, Fiessinger JN. Microvascular involvement in pseudoxanthoma elasticum. Capillaroscopic findings. Presse Med 2004;24;33(8):518–521. Perdu J, Champion K, Emmerich J, Fiessinger JN. Microvascular involvement in pseudoxanthoma elasticum. Capillaroscopic findings. Presse Med 2004;24;33(8):518–521.
7.
Zurück zum Zitat Mansour AM. Systemic associations of angioid streaks. Int Ophthalmol Clin. 1991;31(3):61–8.CrossRefPubMed Mansour AM. Systemic associations of angioid streaks. Int Ophthalmol Clin. 1991;31(3):61–8.CrossRefPubMed
8.
Zurück zum Zitat Georgalas I, Papaconstantinou D, Koutsandrea C, Kalantzis G, Karagiannis D, Georgopoulos G, Ladas I. Angioid streaks, clinical course, complications, and current therapeutic management. Ther Clin Risk Manag. 2009;5(1):81–9.PubMedPubMedCentral Georgalas I, Papaconstantinou D, Koutsandrea C, Kalantzis G, Karagiannis D, Georgopoulos G, Ladas I. Angioid streaks, clinical course, complications, and current therapeutic management. Ther Clin Risk Manag. 2009;5(1):81–9.PubMedPubMedCentral
9.
10.
Zurück zum Zitat Rafałowska J. Genetically determined vascular diseases. Folia Neuropathol. 1993;37(4):210–6. Rafałowska J. Genetically determined vascular diseases. Folia Neuropathol. 1993;37(4):210–6.
11.
Zurück zum Zitat Mendelsohn G, Bulkley BH, Hutchins GM. Cardiovascular manifestations of Pseudoxanthoma elasticum. Arch Pathol Lab Med. 1978;102(6):298–302.PubMed Mendelsohn G, Bulkley BH, Hutchins GM. Cardiovascular manifestations of Pseudoxanthoma elasticum. Arch Pathol Lab Med. 1978;102(6):298–302.PubMed
13.
Zurück zum Zitat Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999;100(21):2168–76.CrossRefPubMed Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999;100(21):2168–76.CrossRefPubMed
14.
Zurück zum Zitat Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000;87(11):1055–62.CrossRefPubMed Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000;87(11):1055–62.CrossRefPubMed
15.
Zurück zum Zitat Bollinger A, Butti P, Barras JP, Trachsler H, Siegenthaler W. Red blood cell velocity in nailfold capillaries of man measured by a television microscopy technique. Microvasc Res. 1974;7(1):61–72.CrossRefPubMed Bollinger A, Butti P, Barras JP, Trachsler H, Siegenthaler W. Red blood cell velocity in nailfold capillaries of man measured by a television microscopy technique. Microvasc Res. 1974;7(1):61–72.CrossRefPubMed
Metadaten
Titel
A case of pseudoxanthoma elasticum with proliferative diabetic retinopathy
verfasst von
Keigo Kakurai
Maiko Hayashi
Kanako Yamada
Norihiko Ishizaki
Yumiko Yonemoto
Seita Morishita
Ryohsuke Kohmoto
Takaki Sato
Teruyo Kida
Tsunehiko Ikeda
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
BMC Ophthalmology / Ausgabe 1/2017
Elektronische ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-017-0569-1

Weitere Artikel der Ausgabe 1/2017

BMC Ophthalmology 1/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.